Nie jesteś zalogowany na forum.
Strony: 1
Certainly, many investigators are evaluating novel approaches to combining rituximab with cytotoxic chemotherapy in vitro, in animal fashions and in clinical trials based mostly on the synergistic results of rituximab signaling and cytotoxic therapy. A number of research have demonstrated in vitro that rituximab is extremely environment friendly at mediating CMC of varied B cell traces in addition to contemporary malignant B cell samples. The expression of complement inhibitory molecules (CD55 and CD59) on malignant B cells correlates with the extent of in vitro lysis (24-29). Follicular lymphoma is extra delicate to rituximab clinically, and follicular lymphoma cells are extra successfully lysed by complement in vitro when in comparison with cells from topics with massive cell lymphoma or mantle cell lymphoma (30). These research typically make the most of serum as a supply of complement, which speaks to the significance of CMC within the circulation, however tells us little about whether or not complement performs a job within the anti-tumor exercise of rituximab inside lymph nodes or at different extravascular websites.
Also visit my web page; Rituximab precio
my homepage :: rituximab fda label (click the up coming webpage)
Offline
Strony: 1